Q2 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript
Good morning. Welcome to Quoin Pharmaceuticals Limited second-quarter fiscal results and business update conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Gordon Dunn, CFO. Please go ahead.
Thank you, and good morning. We appreciate you joining us on today's conference call. With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO.
We are pleased to provide an update on our progress for the second quarter of 2023, as well as discussing our Q2 2023 financial results. Please note that our operational and financial results press release is now available on Quoin's website.
In keeping with our normal procedure, to begin -- Michael will begin a corporate, clinical, and operational update, following which I will review our financial results. I will then hand the call back to Michael for closing comments. We will also be pleased to answer any questions at the end of the call.
Before we begin
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |